Search & Analyze

Sun Pharma Advanced Research Company Ltd.

Business ServicesBusiness Support

www.sparc.life BSE: 532872NSE: SPARC

₹185.50BSE1.85%

16 Sep, 4:01 PM

₹185.50

₹6.11K Cr

3.86

4.63

276.89%

₹191.15

₹182.00

₹289.00

₹108.20

Customise metrics bar

Price Performance

Peer Comparison

Name
PRIME FOCUS PFOCUS	321.00	215.01	24,998.64	0.00	-45.78	-141.44%	1,266.82	23.82%	2.74
SAGILITY SAGILITY	44.91	21.51	21,023.85	0.33	216.81	45.94%	1,963.48	27.59%	13.82
SYNGENE SYNGENE	380.45	69.07	15,357.59	0.33	-9.00	-110.38%	736.00	-15.84%	9.48
HORIZONIND HORIZONIND	53.00		15,279.39	0.00	-11.63	82.25%	200.55	23.08%	3.32
INDGN INDGN	572.90	34.35	13,804.99	0.39	116.20	-0.17%	1,063.10	39.73%	18.92
IGIL IGIL	314.00	22.19	13,569.81	1.60	165.74	30.98%	370.78	23.22%	77.00
NESCO LTD NESCO	1,071.80	18.38	7,551.90	0.64	99.96	3.97%	211.80	9.55%	19.23
Sun Pharma Advanced Research Company Ltd. SPARC	185.50	3.86	6,107.50	0.00	-20.78	59.94%	39.92	314.11%	163.94

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	16.56	16.81	12.86	14.91	27.19	9.64	7.86	8.45	1,853.22	39.92
Expenses	122.39	110.17	115.77	88.60	80.37	61.72	73.58	65.09	80.02	73.92
	-105.83	-93.36	-102.91	-73.69	-53.18	-52.08	-65.72	-56.64	1,773.20	-34.00
	-639.07%	-555.38%	-800.23%	-494.23%	-195.59%	-540.25%	-836.13%	-670.30%	95.68%	-85.17%
	4.40	1.56	0.04	0.19	0.00	9.14	0.01	-12.36	1.80	23.66
Interest	0.91	0.56	1.14	2.80	4.54	6.19	7.52	8.78	11.64	8.13
	3.07	3.14	3.16	3.14	2.95	2.68	2.56	2.57	2.40	2.20
	-105.41	-95.50	-107.17	-79.44	-60.67	-51.81	-75.79	-80.35	1,760.96	-20.67
	-0.36%	-0.42%	-0.15%	-0.09%	1.48%	-0.12%	-0.08%	-0.09%	-0.02%	-0.53%
	-105.79	-95.90	-107.33	-79.51	-59.77	-51.87	-75.85	-80.42	1,761.34	-20.78
	-3.26	-2.96	-3.31	-2.45	-1.84	-1.60	-2.34	-2.48	54.28	-0.64

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
INCOME :
Operating Income	238.78	75.55	71.77	1,879.17
Operating Income (Net)	238.78	75.55	71.77	1,879.17
EXPENDITURE :
Power & Fuel Cost	5.75	6.14	6.33	6.26
Employee Cost	107.00	141.84	153.58	118.02
Operating Expenses	180.31	140.23	114.52	56.00
General and Administration Expenses	154.91	182.20	115.92	88.01
Miscellaneous Expenses	4.87	7.23	4.55	12.11
	452.84	477.64	394.90	280.40
Operating Profit (Excl OI)	-214.06	-402.10	-323.14	1,598.76
	10.88	29.47	1.79	10.95
	-203.18	-372.63	-321.35	1,609.72
Interest	7.63	1.69	9.04	34.13
PBDT	-210.81	-374.32	-330.39	1,575.58
	11.77	12.51	12.39	10.21
Profit Before Taxation & Exceptional Items	-222.58	-386.83	-342.78	1,565.37
Exceptional Income / Expenses				-12.36
	-222.58	-386.83	-342.78	1,553.01
Provision for Tax		0.38	-0.27	-0.19
	-222.58	-387.21	-342.51	1,553.20
Extra items			0.00	0.00
Consolidated Net Profit	-222.58	-387.21	-342.51	1,553.20
Profit Balance B/F	-1,370.58	-1,591.81	-1,978.84	-2,321.60
Appropriations	-1,593.17	-1,979.03	-2,321.35	-768.40
	-6.86	-11.93	-10.55	47.86
Adjusted EPS	-6.86	-11.93	-10.55	47.86

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	32.45	32.45	32.45	32.45
Total Reserves	480.32	93.30	-249.40	1,306.37
Reserve excluding Revaluation Reserve	480.32	93.30	-249.40	1,306.37
	512.78	125.76	-216.95	1,338.83
Unsecured Loans			100.00
Deferred Tax Assets / Liabilities		-1.26	-2.31	-2.27
Other Long Term Liabilities	130.27	118.18	70.57	65.61
Long Term Provisions	8.14	6.05	7.68	12.34
Total Non-Current Liabilities	138.41	122.97	175.93	75.68
Trade Payables	148.25	142.29	113.92	97.15
Other Current Liabilities	24.15	61.88	94.24	87.96
Short Term Borrowings	0.05	47.00	158.19	556.14
Short Term Provisions	6.49	13.89	7.89	12.85
Total Current Liabilities	178.95	265.06	374.24	754.11
Total Liabilities	830.13	513.78	333.22	2,168.61
Gross Block	146.22	157.14	158.11	143.99
Less: Accumulated Depreciation	40.47	49.60	59.35	58.67
Net Block	105.75	107.53	98.76	85.32
Capital Work in Progress	1.87	1.27	0.56	0.50
Long Term Loans & Advances	64.80	67.67	128.19	120.63
Other Non Current Assets	177.61	25.40	25.93	28.52
Total Non-Current Assets	375.16	244.39	307.03	306.18
Currents Investments	290.90	1.80
Sundry Debtors	32.71	15.53	16.06	8.27
Cash and Bank	111.58	155.33	1.96	1.16
Other Current Assets	3.98	42.24	4.20	1,843.28
Short Term Loans and Advances	15.80	54.48	3.98	9.72
Total Current Assets	454.96	269.39	26.20	1,862.43
Net Current Assets (Including Current Investments)	276.02	4.33	-348.04	1,108.32
Total Assets	830.13	513.78	333.22	2,168.61
Contingent Liabilities	83.57	83.57	84.80	84.74
Total Debt	0.05	47.00	258.19	556.14
	15.80	3.88	-6.69	41.25
Adjusted Book Value	15.80	3.88	-6.69	41.25

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
	-222.58	-386.83	-342.78	1,553.01
Adjustment	6.99	-10.91	20.52	41.16
Changes In working Capital	141.11	-27.33	-46.86	-1,864.59
Cash Flow after changes in Working Capital	-74.48	-425.08	-369.12	-270.42
Cash Flow from Operating Activities	-69.12	-429.19	-360.29	-238.78
Cash Flow from Investing Activities	-548.28	391.53	157.66	-23.50
Cash Flow from Financing Activitie	616.76	42.41	199.26	261.39
Net Cash Inflow / Outflow	-0.64	4.74	-3.38	-0.89
Opening Cash & Cash Equivalents	1.22	0.58	5.33	1.96
Effect of Foreign Exchange Fluctuations		0.00	0.01	0.08
Closing Cash & Cash Equivalent	0.58	5.33	1.96	1.16

Ratios

Valuation

3.86

4.63

4.06

87.97

48.82

40.62

Profitability

276.89

163.94

124.17

85.08

82.65

Leverage & Liquidity

0.42

2.47

46.50

Returns

0.00

1.50

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	65.67	65.67	65.67	65.67	65.67	65.67	65.67	65.67	65.67
	2.81	2.37	2.85	2.57	2.43	2.80	2.81	2.91	3.98
	31.52	31.96	31.48	31.76	31.89	31.53	31.52	31.42	30.34
	34.33	34.33	34.33	34.33	34.33	34.33	34.33	34.33	34.33
No. of Shareholders	1,25,184	1,28,205	1,31,034	1,42,864	1,40,724	1,36,997	1,44,810	1,40,625	1,41,957

Corporate Actions

Showing: All

Date	Type	Details
2026-08-03	Board Meeting	Quarterly Results
2026-07-06	AGM
2026-05-11	Board Meeting	Audited Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

Business ServicesBusiness Support

Sun Pharma Advanced Research Company Ltd. operates in the Business Services sector under the Business Support industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

9 members across the board and senior leadership

Kajal Damania

Company Secretary & Compliance Officer

—

Robert J Spiegel